Hui Yang

Novel recombinant human thyroid-stimulating hormone in aiding postoperative assessment of patients with differentiated thyroid cancer—phase I/II study

Xin Zhang, Yansong Lin, N. Niu, 2022, European Journal of Nuclear Medicine and Molecular Imaging.

Novel recombinant human thyroid-stimulating hormone in aiding postoperative assessment of patients with differentiated thyroid cancer—phase I/II study

Jingwen Xu, Xin Zhang, Yansong Lin, 2022, European Journal of Nuclear Medicine and Molecular Imaging.

Influence of radioactive iodine therapy on liver function in patients with differentiated thyroid cancer

Xiangxiang Liu, Z. Meng, Jian Tan, 2018, Nuclear medicine communications.

SIRPα and PD1 expression on tumor-associated macrophage predict prognosis of intrahepatic cholangiocarcinoma

Linping Xu, Wei Li, Hui Yang, 2022, Journal of translational medicine.

Diagnosis and management of gastroenteropancreatic neuroendocrine neoplasms by nuclear medicine: Update and future perspective

Ying Ding, Qiang Li, Hui Yang, 2022, Frontiers in Oncology.

Noninvasive Imaging of Tumor PD-L1 Expression Using [99mTc]Tc-Labeled KN035 with SPECT/CT.

J. Qu, Yingying Zhang, Ning Li, 2022, Molecular pharmaceutics.

Necessity of Internal Monitoring for Nuclear Medicine Staff in a Large Specialized Chinese Hospital

Hui Yang, Chang-song Hou, Qing-Zhao Zhang, 2016, International journal of environmental research and public health.

Donafenib in progressive locally advanced or metastatic radioactive iodine-refractory differentiated thyroid cancer: results of a randomized, multicenter, phase II trial.

Rongfu Wang, Jian Tan, Q. Ji, 2020, Thyroid : official journal of the American Thyroid Association.

To explore the curative effect of CT-guided Iodine-125 radioactive seed implantation in the treatment of stage Ⅳprimary hepatocellular carcinoma

Deyu Li, Lin Zheng, Hui Yang, 2021, Journal of interventional medicine.